Osaic Holdings
GILD icon

Osaic Holdings’s Gilead Sciences GILD Stock Holding History

Osaic Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.9M Sell
252,547
-1,960
-0.8% -$258K 0.04% 490
2026
Q1 		$35.5M Buy
254,507
+12,409
+5% +$1.74M 0.05% 378
2025
Q4 		$29.7M Sell
242,098
-34,969
-13% -$4.25M 0.04% 434
2025
Q3 		$31M Buy
277,067
+72,952
+36% +$8.29M 0.04% 445
2025
Q2 		$22.7M Buy
204,115
+7,166
+4% +$763K 0.04% 458
2025
Q1 		$22.1M Sell
196,949
-53,229
-21% -$5.49M 0.05% 390
2024
Q4 		$21.7M Sell
250,178
-21,218
-8% -$1.91M 0.05% 378
2024
Q3 		$22.8M Sell
271,396
-16,686
-6% -$1.27M 0.05% 366
2024
Q2 		$19.8M Sell
288,082
-25,058
-8% -$1.67M 0.05% 394
2024
Q1 		$22.9M Sell
313,140
-395,116
-56% -$30.4M 0.05% 358
2023
Q4 		$57.4M Sell
708,256
-107,978
-13% -$8.4M 0.1% 190
2023
Q3 		$61.2M Buy
816,234
+318,848
+64% +$24.5M 0.09% 207
2023
Q2 		$38.3M Buy
497,386
+12,695
+3% +$1.01M 0.07% 253
2023
Q1 		$40.2M Sell
484,691
-24,447
-5% -$2.02M 0.08% 240
2022
Q4 		$43.7M Buy
509,138
+58,614
+13% +$4.64M 0.09% 217
2022
Q3 		$27.8M Buy
450,524
+34,839
+8% +$2.2M 0.06% 288
2022
Q2 		$25.7M Buy
415,685
+46,763
+13% +$2.9M 0.06% 309
2022
Q1 		$20.7M Sell
368,922
-10,330
-3% -$660K 0.04% 417
2021
Q4 		$27.5M Buy
379,252
+23,693
+7% +$1.63M 0.05% 336
2021
Q3 		$24.8M Buy
355,559
+35,187
+11% +$2.47M 0.05% 338
2021
Q2 		$22.1M Buy
320,372
+19,169
+6% +$1.28M 0.05% 359
2021
Q1 		$19.5M Buy
301,203
+25,053
+9% +$1.62M 0.05% 368
2020
Q4 		$16.1M Sell
276,150
-58,491
-17% -$3.53M 0.04% 380
2020
Q3 		$21.1M Buy
334,641
+2,271
+0.7% +$157K 0.06% 280
2020
Q2 		$25.4M Sell
332,370
-147,013
-31% -$11.3M 0.09% 232
2020
Q1 		$26M Buy
+479,383
New +$33.1M 0.11% 197

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings's GILD Position: Q2 2026 in Review

Osaic Holdings reduced its Gilead Sciences (GILD) stake by 0.77% in Q2 2026, selling an estimated $258K and leaving 252,547 shares worth $31.9M. The position accounts for 0.04% of the portfolio, ranked #490.

Osaic Holdings first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. The position peaked at $61.2M in Q3 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Osaic Holdings held 252,547 shares of Gilead Sciences worth $31.9M as of Q2 2026.
  • Osaic Holdings sold 1,960 Gilead Sciences shares in Q2 2026, an estimated $258K.
  • Gilead Sciences made up 0.04% of Osaic Holdings's portfolio in Q2 2026, its #490 holding.
  • Osaic Holdings first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Gilead Sciences position peaked at $61.2M in Q3 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.